Engineering B cells to treat and study human disease



Summary

Engineering B cells, the antibody-producing cells of the immune system, offers powerful tools for both treating and studying human diseases. Genetically modified B cells can be designed to produce therapeutic antibodies directly within the patient, offering targeted and long-lasting therapies for autoimmune diseases, cancers, and infections. Beyond therapeutics, engineered B cells serve as valuable research tools. Scientists can manipulate their antibody specificity to investigate disease mechanisms, develop diagnostic assays, and screen for potential drug candidates. B cell engineering holds immense promise for personalized medicine and a deeper understanding of complex immunological processes.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!